Pharmacokinetics Services Market Scope And Analysis

Report Code : TIPRE00007438
Category : Life Sciences

Status : Published
No. of Pages : 174

Buy Now

Pharmacokinetics Services Market Analysis Report 2024 to 2031

Buy Now

Pharmacokinetics Services Market Report Scope

Report Attribute	Details
Market size in 2023	US$ 1,579.87 Million
Market Size by 2031	US$ 874.96 Million
Global CAGR (2023 - 2031)	7.6%
Historical Data	2021-2022
Forecast period	2024-2031
Segments Covered	By Drug Type Small Molecules Large Molecules By Service Type PK/PD Analysis and Reporting Pre clinical ADME and Human Studies Dosing Simulations Risk Analysis By Therapeutic Application Oncology Cardiovascular Diseases Infectious Diseases Autoimmune Diseases Respiratory Disorders Neurological Disorders Gynecological By End User Pharmaceutical and Biotechnology Companies Contract Research Organizations
Regions and Countries Covered	North America US Canada Mexico Europe UK Germany France Russia Italy Rest of Europe Asia-Pacific China India Japan Australia Rest of Asia-Pacific South and Central America Brazil Argentina Rest of South and Central America Middle East and Africa South Africa Saudi Arabia UAE Rest of Middle East and Africa
Market leaders and key company profiles	Charles River Laboratories International Inc Eurofins Scientific SE Evotec SE Certara Inc Parexel International Corp Thermo Fisher Scientific Inc Allucent PACIFIC BIOLABS SGS SA Shanghai Medicilon Inc

Pharmacokinetics Services Market News and Recent Developments

The pharmacokinetics services market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the pharmacokinetics services market are mentioned below:

Thermo Fisher Scientific expanded its clinical research operations with the opening of a state-of-the-art bioanalytical lab in Richmond, Virginia. The new unit will support the burgeoning demand generated in the biopharmaceutical ecosystem for consistent, high-quality laboratory services to accelerate drug development. The Richmond Bioanalytical Lab, whose entities have been operating since 1985, provides services for all phases of small molecule drug, biologics, vaccine, and biomarker development. Drug testing services include drug PK/PD, and immunogenicity and biomarker quantitation to support drug efficacy and safety. (Source: Thermo Fisher Scientific, Press Release, October 2022)
Charles River Laboratories International, Inc., partnered with Kibur Medical to offer exclusive access to its implantable microdevice (IMD) for in vivo preclinical oncology studies. Kibur’s microdevice technology can hold up to 20 different compounds for local administration, which allows it to dose therapies directly into disease tissue, allowing for investigative studies of early-stage compounds where pharmacokinetic properties are poorly understood. (Source: Charles River Laboratories International, Inc., Newsletter, February 2021)

Pharmacokinetics Services Market Report Coverage and Deliverables

The “Pharmacokinetics Services Market Size and Forecast (2021–2031)” report provides a detailed analysis of the market covering the following areas:

Pharmacokinetics services market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
Pharmacokinetics services market trends as well as market dynamics such as drivers, restraints, and key opportunities
Detailed PEST/Porter’s Five Forces and SWOT analysis
Pharmacokinetics services market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments
Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the pharmacokinetics services market
Detailed company profiles